Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer

Nature Communications

Volumn 4, Issue , 2013, Pages

  Di, Li Jun ^a   Byun, Jung S ^a   Wong, Madeline M ^a   Wakano, Clay ^a   Taylor, Tara ^a   Bilke, Sven ^a   Baek, Songjoon ^a   Hunter, Kent ^a   Yang, Howard ^a   Lee, Maxwell ^a   Zvosec, Cecilia ^b   Khramtsova, Galina ^b   Cheng, Fan ^c   Perou, Charles M ^c   Miller, C Ryan ^c   Raab, Rachel ^d   Olopade, Olufunmilayo I ^b   Gardner, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; C TERMINAL BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REPRESSOR PROTEIN; STAT PROTEIN; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

AGGRESSION; CANCER; CARBOHYDRATE; GENOME; INHIBITION; METABOLISM; MOLECULAR ANALYSIS; PROTEIN; STABILIZATION; SURVIVAL; WOMENS HEALTH;

ARTICLE; BREAST CANCER; CALORIC RESTRICTION; CANCER SURVIVAL; DNA REPAIR; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MESENCHYMAL STEM CELL; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN METABOLISM; SURVIVAL PREDICTION;

ALCOHOL OXIDOREDUCTASES; BINDING SITES; BREAST NEOPLASMS; CALORIC RESTRICTION; CELL DIFFERENTIATION; CLUSTER ANALYSIS; DNA REPAIR; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME, HUMAN; GENOMIC INSTABILITY; GLUCOSE; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PROGNOSIS; SMALL MOLECULE LIBRARIES; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84874583084     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2438     Document Type: Article

References (56)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011)
2. Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat. Med. 10, 789-799 (2004) (Pubitemid 39070849)
3. Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 11, 726-734 (2011)
4. Ram, O. et al. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 147, 1628-1639 (2011)
5. Chinnadurai, G. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res. 69, 731-734 (2009)
6. Zhang, Q. et al. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc. Natl Acad. Sci. USA 103, 9029-9033 (2006) (Pubitemid 43902527)
7. Zhang, Q., Piston, D. W. & Goodman, R. H. Regulation of corepressor function by nuclear NADH. Science 295, 1895-1897 (2002) (Pubitemid 34214127)
8. Di, L. J., Fernandez, A. G., De, S. A., Longo, D. L. & Gardner, K. Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat. Struct. Mol. Biol. 17, 1406-1413 (2010)
9. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000)
10. Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010)
11. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008) (Pubitemid 351636299)
12. Creighton, C. J. et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl Acad. Sci. USA 106, 13820-13825 (2009)
13. Herschkowitz, J. I. et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc. Natl. Acad. Sci. USA 109, 2778-2783 (2012)
14. Hildebrand, J. D. & Soriano, P. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol. Cell Biol. 22, 5296-5307 (2002) (Pubitemid 34755743)
15. Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011)
16. Gage, M., Wattendorf, D. & Henry, L. R. Translational advances regarding hereditary breast cancer syndromes. J. Surg. Oncol. 105, 444-451 (2012)
17. Wakano, C., Byun, J. S., Di, L. J. & Gardner, K. The dual lives of bidirectional promoters. Biochim. Biophys. Acta 1819, 688-693 (2012)
18. DeSiervi, A. et al. Transcriptional autoregulation by BRCA1. Cancer Res. 70, 532-542 (2010)
19. Kao, J. et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4, e6146 (2009)
20. Shi, Y. et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735-738 (2003) (Pubitemid 36514114)
21. Wang, J. et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887 (2007) (Pubitemid 46633160)
22. Adamo, A. et al. LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nat. Cell Biol. 13, 652-659 (2011)
23. Wang, Y. et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138, 660-672 (2009)
24. Bhambhani, C., Chang, J. L., Akey, D. L. & Cadigan, K. M. The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets. EMBO J. 30, 2031-2043 (2011)
25. McDonald, O. G., Wu, H., Timp, W., Doi, A. & Feinberg, A. P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 18, 867-874 (2011)
26. Loboda, A. et al. EMT is the dominant program in human colon cancer. BMC Med. Genomics 4, 9 (2011)
27. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008) (Pubitemid 351911867)
28. Buijs, J. T. et al. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am. J. Pathol. 171, 1047-1057 (2007) (Pubitemid 47441001)
29. Zhao, L. J., Subramanian, T., Vijayalingam, S. & Chinnadurai, G. PLDLSdependent interaction of E1A with CtBP: regulation of CtBP nuclear localization and transcriptional functions. Oncogene 26, 7544-7551 (2007) (Pubitemid 350207713)
30. Chung, C. H., Bernard, P. S. & Perou, C. M. Molecular portraits and the family tree of cancer. Nat. Genet. 32(Suppl): 533-540 (2002) (Pubitemid 35435158)
31. Turner, N., Tutt, A. & Ashworth, A. Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer 4, 814-819 (2004) (Pubitemid 39331153)
32. Cieply, B. et al. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer Res. 72, 2440-2453 (2012)
33. Werth, M. et al. The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex. Development 137, 3835-3845 (2010)
34. Bernardo, G. M. et al. FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene doi: 10. 1038/onc. 2012. 62 (2012)
35. Badve, S. et al. FOXA1 expression in breast cancer-correlation with luminal subtype A and survival. Clin. Cancer Res. 13, 4415-4421 (2007) (Pubitemid 47219708)
36. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005) (Pubitemid 41528093)
37. Charafe-Jauffret, E. et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25, 2273-2284 (2006)
38. Kumar, V. et al. Transcription corepressor CtBP is an NAD()-regulated dehydrogenase. Mol. Cell 10, 857-869 (2002) (Pubitemid 35335640)
39. Achouri, Y., Noel, G. & Van, S. E. 2-Keto-4-methylthiobutyrate, an intermediate in the methionine salvage pathway, is a good substrate for CtBP1. Biochem. Biophys. Res. Commun. 352, 903-906 (2007) (Pubitemid 44894370)
40. Straza, M. W. et al. Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 9, 3740-3750 (2010)
41. Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591 (2004) (Pubitemid 39025053)
42. Ewertz, M. et al. Effect of obesity on prognosis after early-stage breast cancer. J. Clin. Oncol 29, 25-31 (2011)
43. Sinicrope, F. A. & Dannenberg, A. J. Obesity and breast cancer prognosis: weight of the evidence. J. Clin. Oncol. 29, 4-7 (2011)
44. Taubes, G. Cancer research. Unraveling the obesity-cancer connection. Science 335, 28 30-32 (2012)
45. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009)
46. Koppenol, W. H., Bounds, P. L. & Dang, C. V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325-337 (2011)
47. Yu, Q. & Heikal, A. A. Two-photon autofluorescence dynamics imaging reveals sensitivity of intracellular NADH concentration and conformation to cell physiology at the single-cell level. J. Photochem. Photobiol. B 95, 46-57 (2009)
48. Uppal, A. & Gupta, P. K. Measurement of NADH concentration in normal and malignant human tissues from breast and oral cavity. Biotechnol. Appl. Biochem. 37, 45-50 (2003) (Pubitemid 36246345)
49. Schwartz, J. P., Passonneau, J. V., Johnson, G. S. & Pastan, I. The effect of growth conditions on NAD and NADH concentrations and the NAD:NADH ratio in normal and transformed fibroblasts. J. Biol. Chem. 249, 4138-4143 (1974)
50. Bergman, L. M., Birts, C. N., Darley, M., Gabrielli, B. & Blaydes, J. P. CtBPs promote cell survival through the maintenance of mitotic fidelity. Mol. Cell Biol. 29, 4539-4551 (2009)
51. Issa, J. P. & Garber, J. E. Time to think outside the (genetic) box. Cancer Prev. Res. 4, 6-8 (2011)
52. Alexander, B. M. et al. DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin. Cancer Res. 16, 5796-5804 (2010)
53. Stratton, M. R. Exploring the genomes of cancer cells: progress and promise. Science 331, 1553-1558 (2011)
54. Bailey, T. L. & Gribskov, M. Methods and statistics for combining motif match scores. J. Comput. Biol. 5, 211-221 (1998) (Pubitemid 28323813)
55. Olive, P. L. & Banath, J. P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1, 23-29 (2006)
56. Li, J. et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat. Commun. 1, 34 (2010).